{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:43:12Z","timestamp":1773733392332,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2020.00057","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T15:48:03Z","timestamp":1582559283000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment"],"prefix":"10.3389","volume":"10","author":[{"given":"Michael W.","family":"Melkus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loc","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif J.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebayo J.","family":"Molehin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samra","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afzal A.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","article-title":"New vaccines for neglected parasitic diseases and dengue","volume":"162","author":"Beaumier","year":"2013","journal-title":"Transl. Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40249-017-0286-2","article-title":"Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?","volume":"6","author":"Bergquist","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"B3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/infdis\/jis524","article-title":"Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis","volume":"208","author":"Bourke","year":"2013","journal-title":"J. Infect. Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.3389\/fimmu.2018.02975","article-title":"Systemic cytokine and chemokine profiles in individuals with Schistosoma mansoni infection and low parasite burden","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/0035-9203(69)90122-9","article-title":"Quantitative comparison of the intensity of Schistosoma mansoni infections in man and experimental animals","volume":"63","author":"Cheever","year":"1969","journal-title":"Trans. R Soc. Trop. Med. Hyg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S.0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","article-title":"Immunology of human schistosomiasis","volume":"36","author":"Colley","year":"2014","journal-title":"Parasite Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"Doenhoff","year":"2008","journal-title":"Curr. Opin. Infect. Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/imcb.12229","article-title":"The anthelmintic drug praziquantel promotes human Tr1 differentiation","volume":"97","author":"Eyoh","year":"2019","journal-title":"Immunol. Cell. Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1258\/0023677011911570","article-title":"An overview of animal models in experimental schistosomiasis and refinements in the use of non-human primates","volume":"35","author":"Farah","year":"2001","journal-title":"Lab. Anim"},{"key":"B11","doi-asserted-by":"publisher","first-page":"703653","DOI":"10.1155\/2014\/703653","article-title":"Monocyte subsets in schistosomiasis patients with periportal fibrosis","volume":"2014","author":"Fernandes","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1128\/IAI.00641-12","article-title":"Progressive cross-reactivity in IgE responses: an explanation for the slow development of human immunity to schistosomiasis?","volume":"80","author":"Fitzsimmons","year":"2012","journal-title":"Infect. Immun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1002605","DOI":"10.1371\/journal.ppat.1002605","article-title":"A novel mouse model of Schistosoma haematobium egg-induced immunopathology","volume":"8","author":"Fu","year":"2012","journal-title":"PLoS Pathog"},{"key":"B14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/QCO.0b013e328359f04a","article-title":"Are new anthelmintics needed to eliminate human helminthiases?","volume":"25","author":"Geary","year":"2012","journal-title":"Curr. Opin. Infect. Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans","volume":"40","author":"Geary","year":"2010","journal-title":"Int. J. Parasitol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0007704","DOI":"10.1371\/journal.pntd.0007704","article-title":"An investigation into the role of chronic Schistosoma mansoni infection on Human Papillomavirus (HPV) vaccine induced protective responses","volume":"13","author":"Gent","year":"2019","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study","volume":"386","year":"2013","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182006001648","article-title":"Biology of the schistosome lung-stage schistosomulum","volume":"134","author":"Gobert","year":"2007","journal-title":"Parasitology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s13071-017-2533-6","article-title":"Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme","volume":"10","author":"Gower","year":"2017","journal-title":"Parasit. Vectors"},{"key":"B20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","article-title":"Schistosomiasis","volume":"26","author":"Gryseels","year":"2012","journal-title":"Infect. Dis. Clin. North Am"},{"key":"B21","doi-asserted-by":"publisher","first-page":"634","DOI":"10.4269\/ajtmh.1994.51.634","article-title":"Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni","volume":"51","author":"Gryseels","year":"1994","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4049\/jimmunol.169.2.929","article-title":"Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease","volume":"169","author":"Henri","year":"2002","journal-title":"J. Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","article-title":"Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers","volume":"60","author":"Ismail","year":"1999","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1086\/422396","article-title":"Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection","volume":"190","author":"Joseph","year":"","journal-title":"J. Infect. Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/422604","article-title":"Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel","volume":"190","author":"Joseph","year":"","journal-title":"J. Infect. Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.actatropica.2016.11.023","article-title":"Initiating NTD programs targeting schistosomiasis and soil-transmitted helminthiasis in two provinces of the Democratic Republic of the Congo, establishment of baseline prevalence for mass drug administration","volume":"166","author":"Kabore","year":"2017","journal-title":"Acta. Trop"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fimmu.2019.00026","article-title":"The C-type lectin receptor-driven, Th17 cell-mediated severe pathology in schistosomiasis, not all immune responses to helminth parasites Are Th2 dominated","volume":"10","author":"Kalantari","year":"2019","journal-title":"Front. Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1399-3089.2010.00591.x","article-title":"Characterization of baboon NK cells and their xenogeneic activity","volume":"17","author":"Kennett","year":"2010","journal-title":"Xenotransplantation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0006852","DOI":"10.1371\/journal.pntd.0006852","article-title":"Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya","volume":"12","author":"Kimani","year":"2018","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12602","DOI":"10.1111\/pim.12602","article-title":"Schistosoma haematobium cercarial infection alters subsequent systemic immune responses to eggs but has minimal impact on immune responses to egg injection of the bladder","volume":"41","author":"Loc","year":"2019","journal-title":"Parasite. Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1128\/IAI.01178-06","article-title":"Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis","volume":"75","author":"Mallevaey","year":"2007","journal-title":"Infect. Immun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1128\/AAC.00173-08","article-title":"Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni","volume":"52","author":"Martins-Leite","year":"2008","journal-title":"Antimicrob. Agents Chemother"},{"key":"B34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1128\/CMR.00046-07","article-title":"Current status of vaccines for schistosomiasis","volume":"21","author":"McManus","year":"2008","journal-title":"Clin. Microbiol. Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4269\/ajtmh.13-0467","article-title":"Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals","volume":"90","author":"Mo","year":"2014","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.1365-3024.1999.00227.x","article-title":"A comparison of re-infection rates with Schistosoma haematobium following chemotherapy in areas with high and low levels of infection","volume":"21","author":"Mutapi","year":"1999","journal-title":"Parasite. Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.1365-3156.2001.00785.x","article-title":"Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Cote d'Ivoire","volume":"6","author":"N'Goran","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"B38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QCO.0000000000000312","article-title":"Mass drug administration and the global control of schistosomiasis: successes, limitations and clinical outcomes","volume":"29","author":"Olveda","year":"2016","journal-title":"Curr. Opin. Infect. Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1046\/j.1365-2567.1999.00887.x","article-title":"Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB\/c mice","volume":"98","author":"Pancre","year":"1999","journal-title":"Immunology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri843","article-title":"The immunobiology of schistosomiasis","volume":"2","author":"Pearce","year":"2002","journal-title":"Nat. Rev. Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fmicb.2016.00594","article-title":"Morphological characteristics of Schistosoma mansoni PZQ-resistant and -susceptible strains are different in presence of praziquantel","volume":"7","author":"Pinto-Almeida","year":"2016","journal-title":"Front. Microbiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e0005180","DOI":"10.1371\/journal.pntd.0005180","article-title":"Schistosoma mansoni infection can jeopardize the duration of protective levels of antibody responses to immunizations against hepatitis b and tetanus toxoid","volume":"10","author":"Riner","year":"2016","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1371\/journal.pntd.0000990","article-title":"Evaluation of a 25-year-program for the control of Schistosomiasis mansoni in an endemic area in Brazil","volume":"5","author":"Sarvel","year":"2011","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"464S","DOI":"10.1093\/ajcn\/66.2.464S","article-title":"Synergism of nutrition, infection, and immunity: an overview","volume":"66","author":"Scrimshaw","year":"1997","journal-title":"Am. J. Clin. Nutr"},{"key":"B45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1046\/j.1464-410x.1999.00313.x","article-title":"The urology of Pharaonic Egypt","volume":"84","author":"Shokeir","year":"1999","journal-title":"BJU Int"},{"key":"B46","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00436-008-0887-6","article-title":"Experimental vaccines in animal models for schistosomiasis","volume":"102","author":"Siddiqui","year":"2008","journal-title":"Parasitol. Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pt.2016.10.010","article-title":"Sm-p80-based schistosomiasis vaccine: preparation for human clinical trials","volume":"33","author":"Siddiqui","year":"2017","journal-title":"Trends Parasitol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/nyas.13866","article-title":"Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter","volume":"1425","author":"Siddiqui","year":"2018","journal-title":"Ann. N Y Acad. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.0105-2896.2004.00197.x","article-title":"The immunobiology of Th1 polarization in high-pathology schistosomiasis","volume":"201","author":"Stadecker","year":"2004","journal-title":"Immunol. Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. (2015)","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect. Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2817","DOI":"10.1371\/journal.pntd.0002817","article-title":"Circulating CD14brightCD16+ 'intermediate' monocytes exhibit enhanced parasite pattern recognition in human helminth infection","volume":"8","author":"Turner","year":"2014","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0005440","DOI":"10.1371\/journal.pntd.0005440","article-title":"The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: an open-label trial","volume":"11","author":"Wajja","year":"2017","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13071-016-1369-9","article-title":"Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?","volume":"9","author":"Wilson","year":"2016","journal-title":"Parasit. Vectors"},{"key":"B54","volume-title":"Schistosomiasis Fact Sheet","year":"2019"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00057\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T14:04:05Z","timestamp":1695823445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2020.00057\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":54,"alternative-id":["10.3389\/fcimb.2020.00057"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.00057","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"article-number":"57"}}